- Home
- MRKR vs KFFB Comparison
MRKR vs KFFB Comparison
Compare MRKR & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- KFFB
- Stock Information
- Founded
- MRKR N/A
- KFFB 2005
- Country
- MRKR United States
- KFFB United States
- Employees
- MRKR N/A
- KFFB N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- MRKR Health Care
- KFFB Finance
- Exchange
- MRKR Nasdaq
- KFFB Nasdaq
- Market Cap
- MRKR 19.1M
- KFFB 21.0M
- IPO Year
- MRKR N/A
- KFFB 2005
- Fundamental
- Price
- MRKR $1.71
- KFFB $3.00
- Analyst Decision
- MRKR Strong Buy
- KFFB
- Analyst Count
- MRKR 3
- KFFB 0
- Target Price
- MRKR $13.17
- KFFB N/A
- AVG Volume (30 Days)
- MRKR 102.6K
- KFFB 6.5K
- Earning Date
- MRKR 08-13-2025
- KFFB 05-12-2025
- Dividend Yield
- MRKR N/A
- KFFB N/A
- EPS Growth
- MRKR N/A
- KFFB N/A
- EPS
- MRKR N/A
- KFFB N/A
- Revenue
- MRKR $5,696,123.00
- KFFB $8,308,000.00
- Revenue This Year
- MRKR N/A
- KFFB N/A
- Revenue Next Year
- MRKR $11.28
- KFFB N/A
- P/E Ratio
- MRKR N/A
- KFFB N/A
- Revenue Growth
- MRKR 71.53
- KFFB 13.79
- 52 Week Low
- MRKR $0.95
- KFFB $1.96
- 52 Week High
- MRKR $5.99
- KFFB $3.62
- Technical
- Relative Strength Index (RSI)
- MRKR 60.22
- KFFB 67.97
- Support Level
- MRKR $1.56
- KFFB $2.91
- Resistance Level
- MRKR $1.93
- KFFB $3.03
- Average True Range (ATR)
- MRKR 0.10
- KFFB 0.10
- MACD
- MRKR 0.02
- KFFB 0.03
- Stochastic Oscillator
- MRKR 57.69
- KFFB 97.83
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.